Development and Validation of a Novel Analytical Method (Ion Pair HPLC) For Separating and Determining Bisoprolol Fumarate and Carvedilol in Pure and Their Pharmaceutical Forms.
DOI:
https://doi.org/10.21123/bsj.2023.8223Keywords:
Bisoprolol Fumarate, Carvedilol, Determining, Ion Pair HPLC, ValidationAbstract
This work shows a new analytical method (ion pair HPLC) for the analysis of Bisoprolol Fumarate (BIS) and Carvedilol (CAR) in bulk and tablet. The developed analytical method has been carried out on an Inertsil ODS-3 5µL column 4.6 X 250 mm (w), as stationary phase using a mobile phase {Acetonitrile/ water 50/50 (v/v) containing sodium heptane sulfonic salt 0.001M as Ion pair agent}. The detection wavelength was 223 nm and the flow rate was 1.5 mL /min. Retention times were 3.5 min of BIS and 5.8 min of CAR. The analytical method has been validated by ICH guidelines. The developed method gave linearity in the concentration range of 20–60 µg/ mL accuracy with mean recovery values between 98-102 % (99.73% for BIS and 101.2% for CAR). The developed method is useful for separating and determining Bisoprolol Fumarate and Carvedilol in their pharmaceutical forms.
Received 13/12/2022
Revised 09/06/2023
Accepted 11/06/2023
Published Online First 20/11/2023
References
Farzam K, Jan A. Beta Blockers. Drugs Sport Seventh Ed. Stat Pearls. 2022; 307–15. PMID:30422501, Bookshilf ID: NBK532906. https://www.ncbi.nlm.nih.gov/books/NBK532906/
The United States Pharmacopeia and National Formulary USP 41 NF 36. 2021.
http://www.usp.org/ https://books.google.com/books/about/USP_41_NF_36_The_United_States_Pharmacop.html?id=LF4PtAEACAAJ
Helmy S, EL-Masry S, Mazyed E, Helmy S AM. Patient-Friendly Extemporaneous Formulation of Bisoprolol : Application to Stability and Bioavailability Studies. Res Sq . 2022;13(3):1–23. https://doi.org/10.1007/s13346-022-01239-x
Logoyda L, Kovalenko S, Abdel-Megied A, Zhulkevych I, Drapak I, Demchuk I, et al. HPLC method development for the analysis of bisoprolol in combined dosage form containing bisoprolol and enalapril and in vitro dissolution studied. Int J Curr Pharm Res. 2019;11(3):186–94. https://doi.org/10.22159/ijap.2019v11i3.32391
Hassan S, Nashat N, Elghobashy M, Abbas S, Moustafa A. Stability-Indicating RP-HPLC and CE Methods for Simultaneous Determination of Bisoprolol and Perindopril in Pharmaceutical Formulation : A Comparative Study. J Chromatogr Sci . 2020;58(8):747–58. https://doi.org/10.1093/chromsci/bmaa031
Alahmad S, Hammad S, Mabrouk M, Mansour F. Development and Validation of Novel RP-HPLC Method for Simultaneous Determination of Ramipril, Hydrochlorothiazide and Bisoprolol in Ternary combinations. Der Pharma Chemica. 2017; 9(20):70-75. https://www.researchgate.net/publication/320963250_Development_and_Validation_of_Novel_RP-HPLC_Method_for_Simultaneous_Determination_of_Ramipril_Hydrochlorothiazide_and_Bisoprolol_in_Ternary_Combinations
Pawar SH, Tamboli A. Patil S. Uv spectrophotometric area under curve method for the simultaneous determination of Bisoprolol fumarate and Cilnidipine in pharmaceutical dosage form. World J Pharm Res. 2020;9(5):1691-1699. https://doi.org/10.20959/wjpr20205-17430
Mishra P. Development and Validation of Q-Absorbance Ratio UV Spectrophotometric Method for Simultaneous Determination of Bisoprolol Fumarate and Cilnidipine in Marketed Formulation Besicor C5. Asian J Pharm. 2022;16(3):905–7. https://doi.org/10.22377/ajp.v16i3.4484
9. Tan Z, Ke G, Huang J, Yang D, Pi M, Li L, et al. Effects of carvedilol on Cardiovascular Events and Mortality in Hemodialysis patients, A Systematic Review and Meta-Analysis. Iran J Kidney Dis. 2020;14(4):256-266. PMID: 32655020. http://www.ijkd.org/index.php/ijkd/article/viewArticle/5234
Anjani Q, Sabri A, Mcguckin M, Li H, Hamid Kh, Donnelly R. In Vitro Permeation Studies on Carvedilol Containing Dissolving Microarray Patches Quantified Using a Rapid and Simple HPLC -UV Analytical Method. AAPS Open. 2022;23(237),2–13. https://doi.org/ 10.1208/s12249-022-02422-6
Ahmed S, Khan A, Sheraz M, Bano R, Ahmad I. Development and Validation of a Stability-Indicating HPLC Method for the Assay of Carvedilol in Pure and Tablet Dosage Forms. Curr Pharm Anal. 2018;14(2),139–52. https://doi.org/10.2174/1573412913666170525122146
Hymavathi KVN, Madhuri S, Sudheer I. Simple and sensitive U.V spectroscopic method development of carvedilol in pure form and dosage form. JGTPS. 2014;5(3):1787–1789. https://www.jgtps.com/admin/uploads/1ENavm.pdf
Shetty D, Narayana B. Simple Methods for the Spectrophotometric Determination of Carvedilol. Int Sch Res Notices. 2012;2012(1). https://doi.org/10.5402/2012/373215
Hammash L, Bitar Y, Trefi S. Novel ion pair hplc methods for the assessment of sitagliptin and pioglitazone in tablets. Res J Pharm Technol. 2019;12(8):3713–9. https://doi.org/10.5958/0974-360X.2019.00635.8
Harron DWG. Technical Requirements for Registration of Pharmaceuticals for Human Use: The ICH Process. In The Textbook of Pharmaceutical Medicine.Wiley Online Library. 2013; 447–60. https://doi.org/10.1002/9781118532331.ch23
Jeber J, Turkey N. Flow Injection Analysis with Turbidity Detection for the Quantitative Determination of Mebeverine Hydrochloride in Pharmaceutical Formulations. Baghdad Sci J. 2022; 19(2021):141–54. https://doi.org/ 10.21123/bsj.2022.19.1.0141
Alsamarrai Kh, Ameen S. Simultaneous Ratio Derivative Spectrophotometric Determination of Paracetamol, Caffeine and Ibuprofen in Their Ternary Form. Baghdad Sci J. 2022; 19(6):1276–1276. https://doi.org/10.21123/bsj.2022.6422
Downloads
Issue
Section
License
Copyright (c) 2023 Baghdad Science Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
